We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on stakeholder engagement conducted by PHE as part of the food and drink reformulation programme.
'Seizures of drugs in England and Wales: user guide' is designed to be a useful reference guide with explanatory notes on seizure of drugs.
Government seeks views on adding pack inserts to tobacco products to encourage smokers to quit.
First published during the 2022 to 2024 Sunak Conservative government
Results from the Surveying Prisoner Crime Reduction (SPCR) survey of adult prisoners sentenced in England and Wales.
This series brings together all documents relating to Chemicals: risk reduction strategies
Three men have been sentenced to a total of three years at Manchester Crown Court after pleading guilty to the illegal sale and supply online of prescription-only medicines and controlled Class B and Class C drugs with a street value...
Sanofi UK is recalling the listed batches of Sabril tablets and Sabril granules as a precautionary measure due to the detection of traces of tiapride in the batches of the source material of manufacturer for vigabatrin.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Other effective medicines are available for epilepsy and bipolar disorder and valproate should only be used if these don’t work or aren’t suitable for an individual patient
Paper prepared by Professor Julia Gog, Cambridge University, predicting transmission reduction by non-pharmaceutical interventions.
The CMA investigated alleged excessive and unfair pricing with respect to liothyronine tablets under Chapter II CA98.
Sets out progress on the calorie reduction programme for the food industry and public health bodies between 2017 and 2021.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).